XML 99 R86.htm IDEA: XBRL DOCUMENT v3.20.2
Business Segment Information - Reconciliation of Segment Revenue, Operating Income, Assets, Depreciation and Amortization, and Capital Expenditures (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2018
Segment Reporting Information [Line Items]                      
Revenue $ 49,244,768 $ 45,366,777 $ 47,417,639 $ 47,864,742 $ 45,637,802 $ 45,239,265 $ 43,319,602 $ 45,392,452 $ 189,893,926 $ 179,589,121 $ 167,939,635
Operating income (6,113,137) $ 404,831 $ 309,515 $ 263,437 179,841 $ 406,694 $ 47,565 $ 477,823 (5,135,354) 1,111,923 1,443,685
Assets $ 44,274,830       $ 39,171,980       44,274,830 39,171,980  
Depreciation and amortization                 391,062 462,407 465,127
Capital expenditures                 369,677 310,222 336,411
Pharmaceutical Distribution                      
Segment Reporting Information [Line Items]                      
Capital expenditures                 201,144 210,161 190,191
Other                      
Segment Reporting Information [Line Items]                      
Capital expenditures                 168,533 100,061 146,220
Operating segments                      
Segment Reporting Information [Line Items]                      
Operating income                 2,204,447 2,051,252 1,981,230
Operating segments | Pharmaceutical Distribution                      
Segment Reporting Information [Line Items]                      
Revenue                 182,467,189 172,813,537 161,699,343
Operating income                 1,807,001 1,671,251 1,626,748
Depreciation and amortization                 203,062 232,735 225,608
Operating segments | MWI Animal Health                      
Segment Reporting Information [Line Items]                      
Revenue                 4,216,462 3,975,232 3,789,759
Operating segments | Global Commercialization Services                      
Segment Reporting Information [Line Items]                      
Revenue                 3,308,640 2,893,109 2,542,971
Operating segments | Other                      
Segment Reporting Information [Line Items]                      
Revenue                 7,525,102 6,868,341 6,332,730
Operating income                 400,139 380,660 355,091
Depreciation and amortization                 77,522 69,824 64,768
Intersegment eliminations                      
Segment Reporting Information [Line Items]                      
Revenue                 (98,365) (92,757) (92,438)
Operating income                 (2,693) (659) (609)
Segment reconciling items                      
Segment Reporting Information [Line Items]                      
Acquisition-related intangibles amortization                 $ 110,478 $ 159,848 $ 174,751